Hospital Aleman Report issue

Academic/Hospital Phase 4
Founded: Buenos Aires Argentina (1938)

Organization Overview

First Clinical Trial
2006
NCT02392910
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Hospital Aleman

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia (Phase 4)

Anemia, Iron-Deficiency (Phase 4)

Heart Failure (Phase 4)

Kidney Diseases (Phase 4)

Renal Insufficiency, Chronic (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 4